Qrg Capital Management, Inc. Sarepta Therapeutics, Inc. Transaction History
Qrg Capital Management, Inc.
- $9.26 Trillion
- Q3 2024
A detailed history of Qrg Capital Management, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Qrg Capital Management, Inc. holds 1,969 shares of SRPT stock, worth $229,959. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,969Holding current value
$229,959% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
529Shares Held
83.9MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.21 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.05 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$731 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$509 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$499 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.2B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...